(Reuters) - San Diego-based Biosite said the Hart-Scott-Rodino period expired without an additional request for information from the U.S. Federal Trade Commission. Beckman Coulter previously announced a tender offer to acquire all of Biosite common stock for $85.00 in cash per share.
Read more at Reuters.com Mergers News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment